Related by context. All words. (Click for frequent words.) 59 John O. Holloszy 57 Bruce Psaty 57 Clinical Antipsychotic Trials 56 Dr. Ziyad Hijazi 56 tribulations Groenveld 55 Intervention Effectiveness 55 Huggins Cams Time 55 Laura Koutsky 55 Robert Carpick 54 Jonathan Drezner 54 CBLC# 54 Dr. Mark Olfson 54 Gary Orfield UCLA 54 Steven Deeks 54 phase IIa clinical 54 BY EDWARD ZERIN 54 Lindsay Farrer 54 multicentre randomized controlled 54 pivotal bioequivalence 53 acai pill 53 placebo controlled multicenter 53 EXPLORE Xa 53 multicenter randomized clinical 53 Bruce Lahn 53 Cholesterol Levels SPARCL 53 AP IMPACT Credibility 53 Intervention Effectiveness CATIE 53 Refractory Angina 53 SAIS Johns Hopkins 53 Steven Gey 53 Mark Tuszynski 53 Renata Pasqualini 52 Lone Simonsen 52 Harold D. Stolovitch 52 Zheng Cui 52 AVI antiviral programs 52 Phase Ib IIa 52 ACOSOG Z# 52 landmark ATHENA 52 Mayo Clinic oncologist 52 EMPOWER ™ 52 Multicenter Automatic Defibrillator Implantation 52 ENDEAVOR IV clinical 52 Richard Kronmal 52 Lisa Bero 52 ABSORB clinical 52 PARC MGH 52 George Coukos 52 Dr. Gianni Belcaro 51 Ovarian Cancer Screening 51 CHARM Added 51 RIO Diabetes 51 Mien Chie Hung 51 Hospitals Leuven Belgium 51 double blinded randomized 51 M. Psaty 51 olaparib 51 Catherine Verfaillie 51 placebo controlled clinical 51 EchoCRT 51 Phase III AFFIRM 51 phase IIb clinical 51 OSU Linus Pauling 51 Julia Hippisley Cox 51 NSABP C 51 Randomized controlled 51 Cardiology Cardiovascular Interventions 51 Randi Hagerman 51 Dr. Gervasio Lamas 51 Ansary Stem Cell 51 Samuel Wickline 51 SPIRIT IV 51 Study ADCS 51 VADT 51 sociologist Edward Laumann 51 Samer Hattar 51 John JP Kastelein 50 Adis Medunjanin awaits 50 Am J Geriatr 50 Chensheng Lu 50 Samuel Issacharoff 50 ENDEAVOR III 50 Phase III placebo controlled 50 ADVANCE PD 50 Keflezighi hobbled 50 Philip Brachman 50 Michael Katze 50 Dr. Denise Faustman 50 Juan Carlos Belmonte 50 HYVET 50 ABSORB trial 50 Emory Winship Cancer 50 HNRCA 50 Kiminobu Sugaya 50 By Eva Norlyk 50 Long Lesion 50 ataluren 50 KwaZulu Natal UKZN 50 TRAIL receptor antibody mapatumumab 50 Aravinda Chakravarti Ph.D. 50 Phase 2b kidney transplant 50 F. Goheen 50 Ezra Susser 50 CAMMS# Phase 2 50 Dr. Eva Schernhammer 50 UW Madison Waisman 50 Prostate Cancer Prevention 50 Joseph Loscalzo 50 TAXUS VI 50 Paul Muntner 50 REGENESIS Phase IIb 50 Dr. Honglei Chen 50 Luke Alphey 50 Edward Giovannucci 50 riociguat 50 Sherine Gabriel 49 NEVO RES 49 CALERIE 49 recurrent glioma 49 Jack Siedlecki Yale 49 CINQUIL 49 Claudia Henschke 49 CALGB 49 Thomas Jessell 49 ONTARGET 49 registrational Phase 49 Johan Auwerx 49 STRIDE PD 49 phase III ACCLAIM 49 ACCORD Lipid 49 al Juhyi 49 Delcath Phase III 49 HORIZONS AMI 49 regenerative biology 49 UC Metabolic Diseases 49 Yuegang Zuo professor 49 scholar Mesfin Woldemariam 49 Phase IIb III 49 Immunology Rheumatology 49 Timothy Salthouse 49 Professor Hardev Pandha 49 Mika Kivimaki 49 National Emphysema Treatment 49 Avshalom Caspi 49 Dr. Elsie Taveras 49 Massimo Cristofanilli MD 49 Tony Wyss Coray 49 Paul Thornalley 49 Kiang Liu 49 Eric Manheimer 49 CLARITY TIMI 49 Jurgen Rehm 49 Caprisa 49 prospective observational studies 49 Alfred I. Neugut 49 HDL Selective Delipidation 49 Carla Vecchiotti 49 Charles B. Nemeroff 49 Clive Svendsen 49 solanezumab 49 HF ACTION 49 Gertrude H. Sergievsky 49 neuropharmacology 49 Barbara Sahakian 49 Myoblast Program 49 Surgery Urology 49 Beatrice Golomb 49 Neal Katyal Georgetown 49 Spine Patient Outcomes 49 TAXUS IV 49 multicenter placebo controlled 49 Cedric Garland 49 Carotid Revascularization Endarterectomy vs. 49 Karl Deisseroth 49 TG MV 49 CAPRIE 48 R. Flum 48 UCLA California NanoSystems 48 HGS# 48 biomathematics 48 AIM HIGH 48 Angela Christiano 48 confirmatory clinical 48 Piero Anversa 48 Multicenter Randomized 48 Hagan Bayley 48 urological oncology 48 radio station KXOK 48 Dr. Douglas Diekema 48 blinded randomized placebo controlled 48 PRIMO CABG2 48 cediranib 48 Advaxis Phase 48 John C. Ruckdeschel 48 Larry Cornman physicist 48 APEX PD 48 Reproductive Genetics 48 Amy Abernethy 48 Prostate Lung Colorectal 48 Molecular Cardiology 48 Rita Redberg 48 Androxal TM 48 ACTIVE W 48 Ruth Faden 48 Prof. Rabani 48 ENDEAVOR IV 48 Elena Losina 48 Myrna Weissman 48 Miguel Nicolelis 48 Saybrook Graduate 48 Dr. Massimo Cristofanilli 48 CALGB # [002] 48 Michael Merzenich 48 AVERROES 48 David Rudovsky 48 Bruce Spiegelman 48 Alison Goate 48 subcutaneous PRO 48 P. Barash 48 Bexion 48 ACCEDE 48 compound INCB# 48 Val HeFT 48 Pericak Vance 48 Asthma Intervention 48 Mika Kivimäki 48 Cascade LifeSciences 48 Greengard lab 48 Shoukhrat Mitalipov 48 Roberto Bolli 48 Farr Curlin 48 Phase III VISTA 48 budesonide MMX Phase III 48 Kent Syverud dean 48 Randomized placebo controlled 48 Canvaxin 48 Maryland Greenebaum Cancer 48 Luigi Fontana 48 EMPHASIS HF trial 48 Stemina 48 MADIT 48 CARE HF 48 Mayo Clinic urologist 48 ALSYMPCA 48 fidaxomicin Phase 3 48 Geotextile tubes 48 Lewis Cantley 48 Gene Expression Laboratory 48 RIO Lipids 48 Olaf Schneewind 48 MGd 48 Curt Furberg 48 Phase 2b RESTORE CLI 48 randomized multicenter trial 48 Hans Keirstead 48 BETAS 48 Medicinal Cannabis Research 48 azilsartan medoxomil 48 PSMA ADC 48 SPIRIT III 48 SWOG 47 Roy Baumeister 47 Marcia Stefanick 47 rALLy clinical trial 47 PFO migraine 47 Agus MD 47 homocysteine lowering 47 Kathleen Dracup 47 ENESTnd 47 Arnold Kriegstein 47 evaluating mipomersen 47 urologic oncology 47 recurrent malignant glioma 47 Agnes Rimando 47 Phase III ADT 47 Cellular Oncogenesis Program 47 OMP #R# 47 Stacy Tessler Lindau 47 ToGA 47 journal Psychological Bulletin 47 NO# [002] 47 challenger Mohsen Rezaei 47 RECORD1 47 Nalini Ranjit 47 multicenter randomized controlled 47 randomized controlled multicenter 47 High Throughput Biology 47 Bayer HealthCare Onyx Pharmaceuticals 47 HHMI Investigator 47 Jordan Steiker 47 MitoQ 47 VTEU 47 Kentucky Gluck Equine 47 PRIMO CABG 47 Jasper Rine 47 Dr. Catherine Verfaillie 47 Gerard Karsenty 47 NIH Vaccine 47 Giulio Maria Pasinetti 47 Elizabeth Selvin 47 Katie Liljenquist 47 GSK# [002] 47 Yoo Ho Yeol 47 genetic epidemiology 47 Cloretazine ® 47 ELACYT 47 CURE AF 47 Evidence Therapeutic 47 Dale Umetsu 47 Cecilia Ramlau Hansen 47 Brian Feagan 47 Albuferon Phase 47 Martin Guthold 47 J. Benkovic 47 PreCISe 47 ADMIRE HF 47 Christiane Reitz 47 Peter Muennig 47 Eva Schernhammer 47 dose escalation clinical 47 EURIDIS 47 Quantitative Biosciences QB3 47 microbiologist Taha 47 telomerase therapeutic 47 multicenter clinical 47 Francesca Bravi 47 Elizabeth Zelinski 47 ASCEND HF 47 HCV RESPOND 2 47 HOPE TOO 47 Jane Visvader 47 neuropsychopharmacology 47 Emily Oken 47 UCSF Diabetes 47 Raloxifene Evaluation MORE 47 Heather Eliassen 47 Dr. Nabil Dib 47 Edge STudy 47 Sorafenib HCC Assessment 47 ganetespib 47 RE LY 47 BZA CE 47 NSABP 47 visilizumab 47 Neurovirology 47 Preventive Medicine ACPM 47 Maria Wawer 47 Pharmaceutical Chemistry 47 Mackay Sim 47 Trey Ideker 47 elotuzumab 47 Simin Nikbin Meydani 47 Neil Scolding 47 neurology neuroscience 47 Dr. Gabriella Gobbi 47 SCD HeFT 47 Guillermo Torre Amione 47 multicenter Phase II 47 Gerold Bepler MD Ph.D. 47 Meta analyzes 47 Werner Hacke 47 Loren Rieseberg 47 JoAnn Manson 47 Evaluative Sciences 47 Demosthenes Panagiotakos 47 placebo controlled Phase III 47 Newswise Scientists 47 Kimmie Ng 47 Friedrich Loeffler institute 47 recurrent glioblastoma multiforme 47 Public Health BUSPH 47 Alastair Compston 47 John Burkoff 47 Aggressive Reduction 47 Phase IIIb clinical 47 genitourinary oncology 47 Kronmal 47 fosbretabulin 47 astrophysical sciences 47 phase Ib clinical 47 AVN# Phase 46 Philip Poi 46 phase IIa 46 NanoBio Corporation 46 Jack VanDerhei Temple 46 transplanted neural stem 46 LabCorp conducts clinical 46 Powell Gene Therapy 46 PLCO 46 M. Califf 46 Neuropharmacology 46 Cardiovascular Biology 46 tremelimumab 46 bioorganic chemistry 46 clinical neuropsychology 46 Lijie Ci 46 PEGINTRON REBETOL combination 46 methodologically rigorous 46 pertuzumab 46 Surado Solutions Inc. 46 imetelstat GRN#L 46 Dermatopathology 46 Agios Pharmaceuticals 46 Cellular Physiology 46 surveys Herbenick 46 CHAMPION PCI 46 multicenter randomized Phase 46 Fred Spoor 46 unfractionated heparin UFH 46 Bengt Winblad 46 Prostate AdenoCarcinoma Treatment 46 IMPACT DCM 46 phase III SIMPADICO 46 Utah SJ Quinney 46 cardiology fellowship 46 BRIM3 46 candidate CRLX# 46 Lester Lefton 46 Emma Hitt 46 Jorge Chavarro 46 neuro oncologist 46 Laboratories MRL 46 trastuzumab DM1 T DM1 46 Edward O. Laumann 46 dose escalation phase 46 Jacques Donnez 46 J. Edward Puzas 46 AVADO 46 Christopher Gelpi 46 Xiaowei Zhuang 46 multicenter Phase III 46 Francine Grodstein 46 Witten Herdecke 46 Tom Misteli 46 viral kinetic 46 Joseph Ragaz 46 NIAID Vaccine Research 46 Lewis Kuller 46 Celine Vachon 46 PERSEUS 46 premed Reynolds 46 Ole Isacson 46 Hongjun Song 46 Ashish K. Jha 46 Wendy Demark Wahnefried 46 Retrovirology 46 TACI Ig 46 MD Dr.PH 46 RE MODEL 46 ALN VSP Phase 46 AIR CF2 46 Ravgen 46 Phase Ib clinical 46 microbial pathogenesis 46 evaluating tivozanib 46 de novo kidney transplant 46 Biochemical Genetics 46 EDEMA3 trial 46 Dr. Vassilios Papadopoulos 46 Mayo Clinic endocrinologist 46 Phase #/#a 46 Jonsson Comprehensive Cancer 46 iniparib 46 Dr. Daniel Offen 46 Richard Compans 46 randomized Phase IIb 46 researcher Hwang Woo 46 Charles H. Hennekens 46 journal Lancet Neurology 46 Experimental Hematology 46 Rheos System 46 Cees Dekker 46 multicenter phase 46 NeuroFlo 46 Erkki Ruoslahti 46 KM Venkat Narayan 46 ORMD 46 lomitapide 46 Sociomedical Sciences 46 Initiate Phase II 46 Molecular Neuroscience 46 Luk Van Parijs 46 EDEMA3 46 Developmental Psychobiology 46 Nancy Padian 46 Dalla Lana School 46 defendant Vincenzo Cannalire 46 Owen Hendley pediatrician 46 ROCKET AF 46 MAGE A3 ASCI 46 alvespimycin 46 Grover Krantz 46 Amato Giaccia 46 CRLX# 46 Laurence Klotz 46 Donny Strosberg 46 Kevin Eggan 46 UCSB Neuroscience 46 poet Elfriede Jelinek 46 Behavioral Pharmacology 46 Novartis Zometa 46 bile duct tumor 45 tumor immunology 45 Pier Paolo Pandolfi 45 MIST II 45 Active Ulcerative Colitis 45 Left Ventricular Dysfunction 45 EVEREST II 45 telcagepant 45 SPIRIT FIRST 45 teriflunomide 45 Houston UTHealth 45 COU AA 45 Bart Hoebel 45 Ken Nagao 45 MEND CABG 45 Phase #b/#a 45 Guoping Feng 45 Nahum Sonenberg 45 Yvonne Greenstreet 45 DMSc 45 Judith Hibbard 45 pediatric rheumatology 45 number NCT# ClinicalTrials.gov 45 CUSTOM III 45 HHMI professors 45 nutritional epidemiology 45 Aflibercept 45 Ronald DePinho 45 Stem Cell Research ISSCR 45 rotary VAD 45 Nikolaos Scarmeas MD 45 Phase Ib II 45 Joann Petrini 45 Kissela 45 INGAP 45 ONCONASE R 45 Shelton Earp 45 Neri Laufer 45 Ichiro Kawachi 45 Universityâ 45 Duke Comprehensive Cancer 45 Gerald Uelmen Santa Clara 45 Cloretazine R 45 TEC #OL 45 journal Nucleic Acids 45 PROTECT II 45 Prostate Disease 45 acyclovir Lauriad R 45 Sabine Bahn 45 Jerry Gurwitz 45 Dr. Shinya Yamanaka 45 Biodesix 45 Rotterdam Erasmus 45 Subgroup analysis 45 lawmaker Hosseini Sobhaninia 45 ancrod 45 Regado Biosciences 45 Timothy P. Clackson 45 Dr. Irving Weissman 45 phase IIb III 45 Hakon Hakonarson 45 lenalidomide Revlimid R 45 Elias Zerhouni 45 Elias Zerhouni MD 45 SORT OUT III 45 Rush Alzheimer Disease 45 Roi Cohen Kadosh 45 Dr. Sudha Seshadri 45 Yunsheng Ma 45 midstage clinical 45 bronchial thermoplasty 45 PROSTVAC VF 45 BRAF inhibitor 45 James Gangwisch 45 Tomas Philipson 45 Axel Ullrich 45 Randomized Double blind 45 TRITON TIMI 45 Neurochemistry 45 Berman Bioethics 45 SIMPADICO 45 Alasdair Coles 45 Single Molecule Biophysics 45 noscapine 45 Phase 1b clinical trials 45 AIDSVAX flunked 45 Nanette Wenger 45 tramiprosate Alzhemed TM 45 New York-Presbyterian/Columbia 45 Transplant Immunology 45 Maxine Waters D Calif 45 MD DrPH 45 blinded randomized 45 Disgraced cloning scientist 45 Wendie Berg 45 journal Arteriosclerosis Thrombosis 45 Clinic Taussig Cancer 45 Susumu Tonegawa 45 Mehmet Toner Harvard 45 Etubics 45 blood clot preventer 45 Charles Perou 45 venlafaxine XR 45 Microbiology Immunology 45 drug TGN# 45 REALITY Trial 45 Academia Sinica Taiwan 45 Current Author Addresses 45 Ivanhoe Newswire Researchers 45 Professor Alan Trounson 45 Elaine Fuchs 45 Glucosamine Chondroitin Arthritis 45 Richard L. Cravatts 45 INTERCEPT red 45 TBC# 45 Cytopathology 45 Matthew Crenson Johns Hopkins 45 Decision Processes 45 Proellex TM 45 Clifford Saper 45 Anil Potti 45 relapsing remitting MS RRMS 45 Vascugel TM 45 GetGoal Phase III 45 evolutionary anthropology 45 canakinumab 45 Consultant Haematologist 45 Kent Vrana 45 Joseph Glenmullen 45 designed chimeric peptide 45 FOLFOX6 chemotherapy regimen 45 Dr. Laikind 45 relapsed MM 45 Motesanib 45 Sibutramine Cardiovascular Outcomes 45 Johns Hopkins Kimmel 45 tanespimycin 45 Matt Friedeman 45 GENASIS clinical 45 transplantation immunology 45 adult mesenchymal stem 45 Ji Xin Cheng 45 LIMR 45 Biomolecular Medicine 45 prospective multicenter randomized 45 Pagoclone 45 Dextofisopam Phase 2b 45 Berkeley Boalt Hall 45 Geiger Gibson RCHN 45 Cannabinor 45 specified primary endpoint 45 Phase 2a clinical 45 Shuvo Roy 45 macromolecular science 45 Nickolas Papadopoulos 45 Robert Blelloch 45 GREENCASTLE Ind. DePauw 45 cilostazol 45 XL# SAR# 45 Phase #b/#a clinical 45 Hwang faked 45 Randy Schekman 45 Phase IIb kidney transplant 45 PCMM IDI 45 designated HVTN 45 Sandro Galea 45 Howard Bassen 45 Sara Mednick 45 Manolis Kellis 45 aleglitazar 45 Deforolimus 45 Robert Plomin 45 Leonard Guarente 45 Adrenomyeloneuropathy AMN 45 Irv Weissman 45 ExTRACT TIMI 45 Mick Bhatia 44 home eldercare evaluation 44 Eric Turkheimer 44 Interdisciplinary Stem Cell 44 Priyamvada Natarajan 44 CATIE AD 44 Provacel 44 HIVNET 44 GIND 44 incyclinide 44 PhD UCSF 44 REMINYL ® 44 ReN# 44 Desmond Ayim Aboagye 44 COR Diabetes 44 veterinary microbiology 44 NCCTG 44 Ph.D. D.Sc. 44 Thurston Arthritis 44 George Kunos 44 randomized controlled clinical 44 Kutluk Oktay 44 gene therapy 44 MD MHSc 44 Jamshed Bharucha 44 Shahin Rafii 44 Harold Willens 44 PhD DSc 44 Graham Colditz 44 everolimus eluting stents 44 OHRI 44 Steven Keteyian 44 Maximum Tolerated Dose MTD 44 Bruce Schackman 44 Sarah Jayne Blakemore 44 deadlocked juries 44 FoldRx Pharmaceuticals Inc. 44 quick witted dork 44 drug Recentin 44 Cancer Immunotherapy 44 Bernard Zinman 44 multicenter trials 44 Ulaby 44 blinded placebo controlled 44 professor Alan Abramowitz 44 Emmanuel Skordalakes 44 Johns Hopkins Wilmer Eye 44 prospective randomized placebo 44 Pyridorin 44 Inje University 44 CB2 selective receptor agonist 44 MBBS Ph.D. 44 antiretroviral naïve 44 Jill Belch 44 Marianne Bertrand 44 Vamsi Mootha 44 Phase Ib IIa clinical 44 Gregory Saathoff 44 Incept 44 Rita F. Redberg 44 Cellular Neurobiology Laboratory 44 mucosal immunology 44 epidemiology biostatistics 44 Professor Shinya Yamanaka 44 blinded randomized controlled 44 evaluating Actimmune 44 Herman Scholtz 44 YONDELIS 44 dimebon latrepirdine 44 Jeanne Loring 44 Gunda Georg 44 OHR/AVR# 44 TriGrid 44 PANVAC VF 44 thorough QT 44 Ophena TM 44 multicenter randomized placebo controlled 44 Jose Baselga 44 biochemistry molecular biology 44 Metin Basoglu 44 Lankenau Institute 44 Andrew Hoeft Edenfield 44 TREAT ALS 44 FACPM 44 Geron Corp. 44 Zhenan Bao 44 AERAS-#/Crucell Ad# 44 phase Ib 44 Matthew Hotopf 44 Jacques Baillargeon 44 novel VDA molecule 44 Ateronon 44 Jaakko Tuomilehto 44 Pulminiq 44 Zemplar Capsules 44 completed postdoctoral fellowship 44 Tolamba 44 Genomic Medicine Institute 44 Alton Boynton 44 Exherin TM 44 Raymond T. Bartus 44 Multicenter 44 Tamas Horvath 44 IIa clinical 44 Phase IIb REGENESIS 44 Mirus Bio 44 dirucotide MBP# 44 Asentar 44 eldercare evaluation 44 Lycera 44 BJPennfan 44 Phase III psoriasis 44 PF # [002] 44 ocrelizumab 44 stage IIIb IV 44 MADIT II 44 clinical pharmacology studies 44 urologic surgery 44 Corlux 44 Marguerite Roza 44 Judy Olian 44 MediGene focuses 44 Norman Hollenberg professor 44 Kaj Blennow 44 Roger Y. Tsien 44 BioAxone 44 Neurology Psychiatry 44 phase IIb study 44 Alpha Tocopherol Beta Carotene 44 oral rivaroxaban 44 mapatumumab 44 Karolinska Institutet Sweden 44 SUCCEED trial 44 Stanley Falkow 44 Matthew Meselson 44 Erkki Ruoslahti MD Ph.D. 44 Randomised 44 WHEL 44 Vitit Muntarbhorn Thai 44 HPTN 44 Onconase 44 Judah Folkman 44 genetically reprogramming 44 Curaxin 44 trials 44 Richard Schilsky 44 Behavioural Neuroscience 44 Parth Chauhan sophomore 44 Phase Ib clinical trials 44 Mark Ratain 44 TOLAMBA 44 pretrials 44 motesanib 44 Phase III registrational 44 journal Alternative Therapies 44 UKPDS 44 galiximab 44 Visual Neuroscience 44 Teriflunomide 44 Neurotrauma 44 Julio Licinio 44 endocrinologist gynecologist 44 Zilver PTX 44 HCV SPRINT 44 Pervasis 44 MD MSHS 44 Shiuan Chen 44 placebo controlled dose escalation 44 GHSU 44 Cedars Sinai Regenerative Medicine 44 Huda Y. Zoghbi 44 neuroimmunology 44 Hoosen Coovadia 44 ANAVEX #-# [001] 44 IMPACT DCM clinical 44 KRN# 44 Kate Winslet Audrey Tautou 44 By Kevin Eigelbach 44 cyclophilin inhibitors 44 prospective nonrandomized 44 phase IIIb 44 CIMZIA TM certolizumab pegol 44 randomized multicenter Phase III 44 VICTOR E3 44 LymphoStat B Phase 44 Colgate Darden Graduate 44 Pimavanserin 44 Stanley B. Prusiner 44 antidepressants fluoxetine 43 myopic CNV 43 Eric Boerwinkle 43 Velcura 43 Kim Seon jong 43 Neal Benowitz 43 Phase 2a trial 43 Lm vaccine 43 Don Ganem 43 Gustavo Saposnik 43 Fondaparinux 43 GAMMAGARD 43 Mark F. Lenzenweger 43 Carigent 43 RSD# oral 43 Raloxifene STAR 43 Dr. Helen Mayberg 43 Thomas Tuschl 43 Jian Liu 43 cardiology proteomics infectious diseases 43 gamma secretase inhibitor 43 Gynecologic Cancer Prevention 43 TAXUS ATLAS 43 Seiki Kawagoe 43 controlled multicenter 43 Ellex 2RT 43 Cappy Surette Navy 43 Wistar Molecular 43 Jayashri Kulkarni 43 Adenoma Prevention 43 Dr. Leonard Wartofsky 43 Alan Marlatt 43 visit http:/www.clinicaltrials.gov/ 43 Omacetaxine 43 MD M.Sc. 43 Zindel Segal 43 tarenflurbil 43 intratumoural 43 croon Honky Tonk Woman 43 Elena Fuentes Afflick 43 Professor Colin Blakemore 43 Alan Aderem 43 Julie C. Lumeng 43 iPrEx 43 CEL SCI Phase III 43 Tyrima 43 HS Sabharwal 43 How Practicing Gratitude 43 Dubuque Theological Seminary 43 Slone Epidemiology Center 43 metastatic castration resistant 43 Kohwi Shigematsu 43 Raymond F. Schinazi 43 NSABP B 43 EEG abnormalities 43 Samuel Stupp 43 Adriane Fugh Berman 43 Ereska 43 preclinically 43 MD DPhil 43 myoblast therapy 43 RhuDex 43 blind randomized controlled 43 multicentre randomized 43 Seymour Benzer 43 Terrence Tumpey 43 orally inhaled migraine 43 Shuming Nie 43 PARTNER Trial 43 DIRECT Trial 43 OvaRex 43 Randomized Phase 43 ZOLINZA 43 Miami Bascom Palmer 43 ENDEAVOR II 43 Eduardo Villamor 43 Kazumi Shiosaki 43 VIR# 43 Obinna Ezeobi Abuja 43 senicapoc 43 TauRx Therapeutics 43 Dr. Manesh Patel 43 By Malcolm Maclachlan 43 Trandolapril 43 pomalidomide 43 Behavioural Medicine 43 Stefano Conti 43 Lori Mosca 43 Prednisporin TM 43 pharmacokinetic characteristics 43 Virginia Darden Graduate 43 Vaxfectin TM 43 David Stuckler 43 Uri Goldbourt 43 rufinamide 43 canagliflozin 43 LibiGel Phase III 43 Reduce Cardiovascular 43 paclitaxel cisplatin 43 CHAVI 43 TTF Therapy 43 aflibercept VEGF Trap 43 scientist Alan Abramowitz 43 Alan Dangour 43 Andrei Borisov 43 Stein Sture 43 Phase IIa clinical 43 postdoctoral trainee 43 Xu Bodong 43 Wellstat 43 Brain Behavior 43 Phase 1a clinical 43 Krembil Neuroscience Centre 43 Yvonne Linney 43 Mitchell Krucoff 43 selenium supplementation 43 CEQ# 43 randomized controlled clinical trials 43 AVOREN 43 Elizabeth Saewyc 43 multicenter prospective 43 CA9 SCAN 43 Emory Transplant 43 UNC Lineberger 43 Benjamin Wolozin 43 Paleoanthropologist 43 initiate Phase 2b 43 ORAL Sync 43 Gheorghiade 43 Paul Pauca 43 Thorough QT 43 TGN# 43 Ryoo Kihl jae 43 REVIVE Diabetes